APLM
Price
$14.50
Change
-$4.43 (-23.40%)
Updated
Jul 13, 04:23 PM (EDT)
Capitalization
41.62M
Intraday BUY SELL Signals
PRAX
Price
$314.31
Change
-$10.68 (-3.29%)
Updated
Jul 13, 04:59 PM (EDT)
Capitalization
9.06B
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APLM vs PRAX

APLM vs PRAX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APLM vs. PRAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and PRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (APLM: $18.93 vs. PRAX: $324.99)
Brand notoriety: APLM and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 24% vs. PRAX: 38%
Market capitalization -- APLM: $41.62M vs. PRAX: $9.06B
APLM [@Biotechnology] is valued at $41.62M. PRAX’s [@Biotechnology] market capitalization is $9.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $123.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, APLM is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 4 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • APLM’s TA Score: 4 bullish, 5 bearish.
  • PRAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, APLM is a better buy in the short-term than PRAX.

Price Growth

APLM (@Biotechnology) experienced а -1.20% price change this week, while PRAX (@Biotechnology) price change was +2.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.46%. For the same industry, the average monthly price growth was +6.93%, and the average quarterly price growth was +1806.10%.

Reported Earning Dates

PRAX is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Biotechnology (-3.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($9.06B) has a higher market cap than APLM($41.6M). PRAX YTD gains are higher at: 10.263 vs. APLM (1.257). APLM has higher annual earnings (EBITDA): -56.38M vs. PRAX (-357.2M). PRAX has less debt than APLM: PRAX (1.44M) vs APLM (4.72M). APLM (0) and PRAX (0) have equivalent revenues.
APLMPRAXAPLM / PRAX
Capitalization41.6M9.06B0%
EBITDA-56.38M-357.2M16%
Gain YTD1.25710.26312%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A787M-
Total Debt4.72M1.44M329%
TECHNICAL ANALYSIS
Technical Analysis
APLMPRAX
RSI
ODDS (%)
Bearish Trend 4 days ago
40%
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
63%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
48%
Bullish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
78%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
APLM
Daily Signal:
Gain/Loss:
PRAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VESGX54.040.22
+0.41%
Vanguard Global ESG Select Stk Admiral
VYSVX23.110.07
+0.30%
Vericimetry US Small Cap Value
SCINX74.470.19
+0.26%
DWS CROCI International S
FSNIX18.790.02
+0.11%
Fidelity Advisor Asset Manager 60% I
QDVSX21.00-0.02
-0.10%
FI Instl ESG Stck Fd for Ret Plns

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
-0.11%
SNTI - APLM
47%
Loosely correlated
+3.00%
HCWB - APLM
45%
Loosely correlated
-2.05%
PRAX - APLM
39%
Loosely correlated
-2.44%
MGX - APLM
37%
Loosely correlated
+0.79%
IPHA - APLM
36%
Loosely correlated
-0.28%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-2.44%
BEAM - PRAX
40%
Loosely correlated
-8.77%
ANRO - PRAX
38%
Loosely correlated
-4.20%
BHVN - PRAX
37%
Loosely correlated
-7.39%
RAPP - PRAX
35%
Loosely correlated
-0.71%
TOVX - PRAX
35%
Loosely correlated
+3.16%
More